Key takeaways
The current Terms of Use exclude the EU, the EEA and the UK by name.
The EEA restriction also covers Norway, Iceland and Liechtenstein, so it is wider than the EU alone.
An account opened in the US or a US NPI does not remove the location-based restriction.
For a European team, access, guideline coverage and the data processing agreement are separate checks for any alternative.
Current availability signals
Top-ranked alternative; confirm your contract
Vera Health
Vera Health ranks first in our 2026 clinical AI evaluation. The vendor says it is available across the EU and the UK and publishes a data processing addendum covering GDPR and UK GDPR. Those are vendor statements: test answers on your own cases and check which terms apply to an individual sign-up versus an organisational contract.
Subscription reference
UpToDate
Check your institution’s access or the individual price, and which AI features the licence includes. An answer in your language does not mean your national guidelines were used.
EU offering to confirm
DynaMed / Dyna AI
EBSCO publishes a Dyna AI page aimed at the EU. Ask which languages, features and terms apply to the offering available to your organisation.
EU, EEA and UK excluded
OpenEvidence
Section 1 of the September 17 terms names the excluded regions. Check the current terms before travel or any change of location.
Which European countries are affected?
Section 1 of the Terms of Use is the direct source for access. It names the EU, the EEA and the UK, alongside countries under a US trade embargo. This is a stated geographic restriction, not a language limitation or a login outage.
- •France, Germany, Spain, Italy, Ireland, the Netherlands and every other EU member state: excluded as part of the EU.
- •Norway, Iceland and Liechtenstein: excluded through the EEA restriction.
- •United Kingdom: named separately, regardless of its status outside the EU.
- •Switzerland: not named. Ask OpenEvidence to confirm eligibility and which professional credentials it accepts.
Existing accounts, NPIs and travel
An account opened in the US or a US professional identifier does not lift the geographic restriction. The terms also separate where you use the service from using it to give clinical guidance to people in excluded regions. Check both before travelling or working across borders; a VPN does not change the vendor’s stated permission to use the service.
What the privacy policy does and does not tell you
The privacy policy revised on September 17 describes data transfers to the US and other jurisdictions and no longer contains earlier wording about countries with stricter privacy laws. That change is not an announcement that Europe has reopened: the restrictions are still in the Terms of Use.
Comparing alternatives for a European practice
For a European team, product access, the language of answers and the guidelines a tool cites are three separate questions. Run each shortlisted tool on the same non-identifying cases before choosing.
- •Start with Vera Health, our top-ranked tool: read its data processing addendum and check whether its answers cite the national guidelines you follow, since the vendor does not publish country-by-country guideline coverage.
- •Compare cited recommendations with your national guidance, and open the original sources rather than assuming a citation supports the answer.
- •Check individual pricing, institutional licences and which AI features each plan includes.
- •Ask how prompts are retained, which subprocessors are used, and what terms apply to patient data.